SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Park Joo Seok) "

Sökning: WFRF:(Park Joo Seok)

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Kim, Joon Tae, et al. (författare)
  • Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial : Rationale and design
  • 2023
  • Ingår i: International Journal of Stroke. - : SAGE Publications. - 1747-4930 .- 1747-4949. ; 18:8, s. 1015-1020
  • Tidskriftsartikel (refereegranskat)abstract
    • Rationale: The optimal duration of dual antiplatelet therapy (DAPT) with clopidogrel-aspirin for the large artery atherosclerotic (LAA) stroke subtype has been debated. Aims: To determine whether the 1-year risk of recurrent vascular events could be reduced by a longer duration of DAPT in patients with the LAA stroke subtype. Methods and study design: A total of 4806 participants will be recruited to detect a statistically significant relative risk reduction of 22% with 80% power and a two-sided alpha error of 0.05, including a 10% loss to follow-up. This is a registry-based, multicenter, prospective, randomized, open-label, blinded end point study designed to evaluate the efficacy and safety of a 12-month duration of DAPT compared with a 3-month duration of DAPT in the LAA stroke subtype. Patients will be randomized (1:1) to either DAPT for 12 months or DAPT for 3 months, followed by monotherapy (either aspirin or clopidogrel) for the remaining 9 months. Study outcomes: The primary efficacy outcome of the study is a composite of stroke (ischemic or hemorrhagic), myocardial infarction, and all-cause mortality for 1 year after the index stroke. The secondary efficacy outcomes are (1) stroke, (2) ischemic stroke or transient ischemic attack, (3) hemorrhagic stroke, and (4) all-cause mortality. The primary safety outcome is major bleeding. Discussion: This study will help stroke physicians determine the appropriate duration of dual therapy with clopidogrel-aspirin for patients with the LAA stroke subtype. Trial registration: URL: https://cris.nih.go.kr/cris. CRIS Registration Number: KCT0004407.
  •  
2.
  • Niemi, MEK, et al. (författare)
  • 2021
  • swepub:Mat__t
  •  
3.
  •  
4.
  • Abbafati, Cristiana, et al. (författare)
  • 2020
  • Tidskriftsartikel (refereegranskat)
  •  
5.
  • Kim, Se-Hoon, et al. (författare)
  • Nanophase oxalate precursors of thermoelectric CoSb3 by controlled coprecipitation predicted by thermodynamic modeling
  • 2016
  • Ingår i: Advanced Powder Technology. - : Elsevier. - 0921-8831 .- 1568-5527. ; 27:2, s. 773-778
  • Tidskriftsartikel (refereegranskat)abstract
    • The precursors for the formation of thermoelectric skutterudite CoSb3 nanoparticles are predicted by thermodynamic modeling of the complex chemical species. Based on the results, equimolar mixture of CoC2O4 center dot 2H(2)O and Sb(C2O4) OH are successively co-precipitated under controlled conditions of pH = 2.7 and concentration of reactants. The as synthesized powder was decomposed at 350 degrees C to remove the organic molecules and further reduced to CoSb3 phase by heating at 530 degrees C under hydrogen flow. The obtained powder was consolidated by spark plasma sintering (SPS). CoSb3 prepared by controlled chemical co-precipitation has p-type behavior with a positive sign of the Seebeck coefficient. TE transport properties were measured, which revealed that the Seebeck coefficient increased 2.5 times with increasing the temperature and it is lower than the ball milled CoSb3. Thermal conductivity of sintered CoSb3 at 773 K starts from 0.06 W/cm K at room temperature and decreases to 0.04 W/cm K at 700 K, which is lower than the bulk counterpart. The ZT of coprecipitated CoSb3 and SPS consolidated at 773 K shows 2 times higher than the ball milled one. (C) 2016 The Society of Powder Technology Japan. Published by Elsevier B.V. and The Society of Powder Technology Japan. All rights reserved.
  •  
6.
  • Park, Byungkyu Brian, et al. (författare)
  • Connected vehicle data for crash hotspots
  • 2018
  • Konferensbidrag (refereegranskat)abstract
    • Identifying crash hotspots help traffic engineers implementing countermeasures to improve transportation system safety. However, given it typically takes 12 to 18 months to obtain crash reports, the crash hotspots based on actual crash reports might not be applicable (as the hotspot locations often change). In order to identify hotspots more timely than current practice, we have investigated the basic safety message (BSM) including equipped vehicle deceleration data at every 0.1 seconds from connected vehicles. Based on the safety pilot study data from April 2013, we proposed “extreme braking event” as a crash surrogate. The extreme braking event was defined as a longitudinal deceleration rate greater than 0.6 g (or 19.32 ft/s2). When comparison was made between the actual crash (i.e., crash rate) and the extreme braking event (i.e., event rate based on the number of equipped vehicles) at the same freeway segments in the city of Ann Arbor, the proposed extreme braking event showed high correlation (over 0.7). In addition, top 5 actual crash hotspots (about 50% of crashes out of 38 segments) were identified by using top 8 extreme braking event measures. Thus, our research indicates that the proposed extreme braking event measure has of great potential to identify crash hotspots in timely manner than the current practice based on delayed crash reports.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy